Abstract
Background/objective:
IGF-binding protein (IGFBP)-2 is the principal IGFBP produced by white adipocytes during adipogenesis, and circulating levels are reduced in obesity. Overexpression of IGFBP-2 in transgenic mice prevents obesity, but depot-specific effects of IGFBP-2 on adipo/lipogenesis are unknown. The present study aimed to investigate whether IGFBP-2 affects adipo/lipogenesis in a depot-specific manner and explore potential mechanisms.
Methods:
Following adipocyte characterisation, IGFBP-2 levels were measured from human subcutaneous and visceral preadipocytes, and IGFBP-2 dose–responses were then undertaken with exogenous IGFBP-2 in an in vitro IGF-I-free system to examine adipo/lipogenesis. Following this, both types of adipocytes were transfected with human siRNA IGFBP-2 to assess auto-/para-/intra-crine effects, with and without additional add-back IGFBP-2. To elucidate the potential mechanisms, visceral preadipocytes were treated with either wild-type or Heparin Binding Domain (HBD)-mutant IGFBP-2 (which is unable to bind to cell-surface components), and experiments were also undertaken using Echistatin (an integrin receptor blocker). Outcomes included gene expression profiles, protein levels and phosphorylation and lipid staining.
Results:
Human visceral adipocytes produced significantly more IGFBP-2 than subcutaneous adipocytes. Subsequent dose–responses to IGFBP-2 demonstrated significant reductions in adipo/lipogenesis in visceral, but not subcutaneous, adipocytes in response to increasing IGFBP-2. Silencing IGFBP-2 resulted in exaggerated adipo/lipogenesis in visceral, but not subcutaneous, adipocytes, an effect completely inhibited by add-back IGFBP-2. These effects occurred in the absence of changes in IGF-I levels. HBD-mutant IGFBP-2 had reduced effects compared with wild-type IGFBP-2. Wild-type IGFBP-2 increased phosphorylation of focal adhesion kinase (FAK) and decreased phosphatase and tensin homolog (PTEN) levels, suggestive of integrin-mediated signalling. Blockade of this signalling, using Echistatin, completely negated the effects of IGFBP-2 on visceral adipo/lipogenesis.
Conclusion:
IGFBP-2 inhibits both adipogenesis and lipogenesis in visceral, but not subcutaneous, adipocytes. This depot-specific impairment appears to be independent of IGF-I and involves cell-surface association of IGFBP-2 and activation of integrin signalling pathways.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Swinburn BA, Sacks G, Hall KD, McPherson K, Finegood DT, Moodie ML et al. The global obesity pandemic: shaped by global drivers and local environments. Lancet 2011; 378: 804–814.
Tataranni PA, Ravussin E . Effect of fat intake on energy balance. Ann NY Acad Sci 1997; 819: 37–43.
Arner E, Westermark PO, Spalding KL, Britton T, Rydén M, Frisén J et al. Adipocyte turnover: relevance to human adipose tissue morphology. Diabetes 2010; 59: 105–109.
Spalding KL, Arner E, Westermark PO, Bernard S, Buchholz BA, Bergmann O et al. Dynamics of fat cell turnover in humans. Nature 2008; 453: 783–787.
Spiegelman BM, Flier JS . Adipogenesis and obesity: rounding out the big picture. Cell 1996; 87: 377–389.
Attie AD, Scherer PE . Adipocyte metabolism and obesity. J Lipid Res 2009; 50: S395–S399.
Guilherme A, Virbasius JV, Puri V, Czech MP . Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 2008; 9: 367–377.
Larsson B . Obesity, fat distribution and cardiovascular disease. Int J Obes 1991; 15: 53–57.
Wajchenberg BL . Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000; 21: 697–738.
Ibrahim MM . Subcutaneous and visceral adipose tissue: Structural and functional differences. Obes Rev 2010; 11: 11–18.
Brun RP, Kim JB, Hu E, Altiok S, Spiegelman BM . Adipocyte differentiation: a transcriptional regulatory cascade. Curr Opin Cell Biol 1996; 8: 826–832.
Gregoire F, Smas C, Sul H . Understanding adipocyte differentiation. Physiol Rev 1998; 78: 783–809.
Cristancho A, Lazar M . Forming functional fat: a growing understanding of adipocyte differentiation. Nat Rev Mol Cell Biol 2011; 28: 722–734.
Smith PJ, Wise LS, Berkowitz R, Wan C, Rubin CS . Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3-L1 adipocytes. J Biol Chem 1988; 263: 9402–9408.
Russo VC, Gluckman PD, Feldman EL, Werther GA . The insulin-like growth factor system and its pleiotropic functions in brain. Endocr Rev 2005; 26: 916–943.
Boney CM, Moats-Staats BM, Stiles AD, D'Ercole AJ . Expression of insulin-like growth factor-I (IGF-I) and IGF-binding proteins during adipogenesis. Endocrinology 1994; 135: 1863–1868.
Bhala A, Harris M, Zirin S, Corcoran L, Cohen P . Insulin-like growth factor axis parameters in sick hospitalized neonates. J Pediatr Endocrinol Metab 1998; 11: 451–459.
Sabin MA, Russo VC, Azar WJ, Yau SW, Kiess W, Werther GA . IGFBP-2 at the interface of growth and metabolism- implications for childhood obesity. Pediatr Endocrinol Rev 2011; 8: 382–393.
Sabin MA, Yau SW, Russo VC, Clarke IJ, Dunshea FR, Chau J et al. Dietary monounsaturated fat in early life regulates IGFBP2: implications for fat mass accretion and insulin sensitivity. Obesity 2011; 19: 2374–2381.
Nam S, Lee E, Kim K, Cha B, Song Y, Lim S . Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone. Int J Obes Relat Metab Disord 1997; 21: 355–359.
Ballerini MG, Ropelato MG, Domene HM, Pennisi P, Heinrich JJ, Jasper HG . Differential impact of simple childhood obesity on the components of the growth hormone-insulin-like growth factor (IGF)-IGF binding proteins axis. J Pediatr Endocrinol Metab 2004; 17: 749–757.
Claudio M, Benjamim F, Riccardo B, Massimiliano C, Francesco B, Luciano C . Adipocytes IGFBP-2 expression in prepubertal obese children. Obesity 2010; 18: 2055–2057.
Li Z, Picard F . Modulation of IGFBP2 mRNA expression in white adipose tissue upon aging and obesity. Horm Metab Res 2010; 787–791.
Wheatcroft S, Kearney M, Shah A, Ezzat V, Miell J, Modo M . IGF-binding protein-2 protects against the development of obesity and insulin resistance. Diabetes 2007; 56: 284–294.
Russo VC, Schütt BS, Andaloro E, Ymer SI, Hoeflich A, Ranke MB et al. Insulin-like growth factor binding protein-2 binding to extracellular matrix plays a critical role in neuroblastoma cell proliferation, migration, and invasion. Endocrinology 2005; 146: 4445–4455.
Russo VC, Bach LA, Fosang AJ, Baker NL, Werther GA . Insulin-like growth factor binding protein-2 binds to cell surface proteoglycans in the rat brain olfactory bulb. Endocrinology 1997; 138: 4858–4867.
Shen X, Xi G, Maile LA, Wai C, Rosen CJ, Clemmons DR . Insulin-like growth factor (IGF) binding protein 2 functions coordinately with receptor protein tyrosine phosphatase β and the IGF-I receptor to regulate IGF-I-stimulated signaling. Mol Cell Biol 2012; 32: 4116–4130.
Schutt B, Langkamp M, Rauschnabel U, Ranke M, Elmlinger M . Integrin-mediated action of insulin-like growth factor binding protein-2 in tumor cells. J Mol Endocrinol 2004; 32: 859–868.
Wheatcroft SB, Kearney MT . IGF-dependent and IGF-independent actions of IGF-binding protein-1 and -2: implications for metabolic homeostasis. Trends Endocrinol Metab 2009; 20: 153–162.
Xi G, Solum MA, Wai C, Maile LA, Rosen CJ, Clemmons DR . The heparin-binding domains of IGFBP-2 mediate its inhibitory effect on preadipocyte differentiation and fat development in male mice. Endocrinology 2013; 154: 4146–4157.
Yau SW, Henry BA, Russo VC, McConell GK, Clarke IJ, Werther GA et al. Leptin enhances insulin sensitivity by direct and sympathetic nervous system regulation of muscle IGFBP-2 expression: evidence from nonrodent models. Endocrinology 2014; 155: 2133–2143.
Hu ED, Kim JB, Sarraf P, Spiegelman BM . Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPAR gamma. Science 1996; 274: 2100–2103.
Smas CM, Sul HS . Pref-1 a protein containing EGF-like repeats, inhibits adipocyte differentiation. Cell 1993; 73: 725–734.
Kovacova Z, Tencerova M, Roussel B, Wedellova Z, Rossmeislova L, Langin D et al. The impact of obesity on secretion of adiponectin multimeric isoforms differs in visceral and subcutaneous adipose tissue. Int J Obes 2012; 36: 1360–1365.
Sabin MA, Crowne EC, Stewart CE, Hunt LP, Turner SJ, Welsh GI et al. Depot-specific effects of fatty acids on lipid accumulation in children's adipocytes. Biochem Biophys Res Commun 2007; 361: 356–361.
Einstein FH, Atzmon G, Yang XM, Ma XH, Rincon M, Rudin E et al. Differential responses of visceral and subcutaneous fat depots to nutrients. Diabetes 2005; 54: 672–678.
Lihn AS, Bruun JM, He GS, Pedersen SB, Jensen PF, Richelsen B . Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects. Mol Cell Endocrinol 2004; 219: 9–15.
Holly JMP, Sabin MA, Perks CM, Shield JP . Adipogenesis and IGF-1. Metab Syndr Relat Disord 2006; 4: 43–50.
Kuang Z, Yao S, Keizer DW, Wang CC, Bach LA, Forbes BE et al. Structure, dynamics and heparin binding of the C-terminal domain of insulin-like growth factor-binding protein-2 (IGFBP-2). J Mol Biol 2006; 364: 690–704.
Lin YT, Tang CH, Chuang WJ, Wang SM, Huang TF, Fu WM . Inhibition of adipogenesis by RGD-dependent disintegrin. Biochem Pharmacol 2005; 70: 1469–1478.
Liu J, DeYoung SM, Zhang M, Zhang M, Cheng A, Saltiel AR . Changes in integrin expression during adipocyte differentiation. Cell Metab 2005; 2: 165–177.
Bretscher MS . Circulating integrins: alpha 5 beta 1, alpha 6 beta 4 and Mac-1, but not alpha 3 beta 1, alpha 4 beta 1 or LFA-1. EMBO J 1992; 11: 405–410.
Caswell PT, Norman JC . Integrin trafficking and the control of cell migration. Traffic 2006; 7: 14–21.
Wang Y, Zhao L, Smas C, Sul HS . Pref-1 interacts with fibronectin to inhibit adipocyte differentiation. Mol Cell Biol 2010; 30: 3480–3492.
Luk CT, Shi SY, Cai EP, Sivasubramaniyam T, Schroer SA, Woo M . Adipocyte-specific FAK deletion in mice leads to insulin resistance but divergent adipose tissue remodelling under lean and obese conditions. Can J Diabetes 2013; 37: 433–434.
Acknowledgements
This work was supported by Murdoch Childrens Research Institute. Authors from the Murdoch Childrens Research Institute are supported in part by the Victorian Government Operational Infrastructure Support Program. MAS is supported through a National Health and Medical Research Council Professional Training Fellowship APP1012201. SWY is a recipient of an Australian Postgraduate Award scholarship.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
A part of this work was presented at the Annual Scientific Meeting of the Endocrine Society of Australia, Sydney, Australia, 25–28 August 2013 and the 16th International Congress of Endocrinology and the Endocrine Society’s 96th Annual Meeting and Expo, Chicago, USA, 20–24 June 2014.
Supplementary Information accompanies this paper on International Journal of Obesity website
Supplementary information
Rights and permissions
About this article
Cite this article
Yau, S., Russo, V., Clarke, I. et al. IGFBP-2 inhibits adipogenesis and lipogenesis in human visceral, but not subcutaneous, adipocytes. Int J Obes 39, 770–781 (2015). https://doi.org/10.1038/ijo.2014.192
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ijo.2014.192
This article is cited by
-
Functionally enhanced placenta-derived mesenchymal stem cells inhibit adipogenesis in orbital fibroblasts with Graves’ ophthalmopathy
Stem Cell Research & Therapy (2020)
-
Serum IGF-binding protein 2 (IGFBP-2) concentrations change early after gastric bypass bariatric surgery revealing a possible marker of leptin sensitivity in obese subjects
Endocrine (2019)
-
Relationship of circulating insulin-like growth factor-I and binding proteins 1–7 with mammographic density among women undergoing image-guided diagnostic breast biopsy
Breast Cancer Research (2019)